These data suggest that FOXO3A is not required for cyclin D1 repression in these cells and that cyclin D1 down‐regulation in MCL cells after DFO treatment is not directly mediated by PHD1 hydroxylase. The gene discussed is FOXO3; the disease is mantle cell lymphoma.